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Magnetic resonance imaging (MRI) data is generated by a complex procedure. 
Many possible sources of error exist which can lead to a worse signal. For example, 
hidden defective components of a MRI-scanner, changes in the static magnetic field 
caused by a person simply moving in the MRI scanner room as well as changes in the 
measurement sequences can negatively affect the signal-to-noise ratio (SNR). A 
comprehensive, reproducible, quality assurance (QA) procedure is necessary, to ensure 
reproducible results both from the MRI equipment and the human operator of the 
equipment. To examine the quality of the MRI data, there are two possibilities. On the 
one hand, water or gel-filled objects, so-called "phantoms", are regularly measured. 
Based on this signal, which in the best case should always be stable, the general 
performance of the MRI scanner can be tested. On the other hand, the actually 
interesting data, mostly human data, are checked directly for certain signal parameters 
(e.g., SNR, motion parameters). 
This thesis consists of two parts. In the first part a study-specific QA-protocol was 
developed for a large multicenter MRI-study, FOR2107. The aim of FOR2107 is to 
investigate the causes and course of affective disorders, unipolar depression and 
bipolar disorders, taking clinical and neurobiological effects into account. The main 
aspect of FOR2107 is the MRI-measurement of more than 2000 subjects in a 
longitudinal design (currently repeated measurements after 2 years, further 
measurements planned after 5 years). To bring MRI-data and disease history together, 
MRI-data must provide stable results over the course of the study. Ensuring this 
stability is dealt with in this part of the work. An extensive QA, based on phantom 
measurements, human data analysis, protocol compliance testing, etc., was set up. In 
addition to the development of parameters for the characterization of MRI-data, the 
used QA-protocols were improved during the study. The differences between sites and 
the impact of these differences on human data analysis were analyzed. The 
comprehensive quality assurance for the FOR2107 study showed significant 
differences in MRI-signal (for human and phantom data) between the centers. 
Occurring problems could easily be recognized in time and be corrected, and must be 
included for current and future analyses of human data. 
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For the second part of this thesis, a QA-protocol (and the freely available 
associated software "LAB-QA2GO") has been developed and tested, and can be used 
for individual studies or to control the quality of an MRI-scanner. This routine was 
developed because at many sites and in many studies, no explicit QA is performed 
nevertheless suitable, freely available QA-software for MRI-measurements is available. 
With LAB-QA2GO, it is possible to set up a QA-protocol for an MRI-scanner or a study 
without much effort and IT knowledge. 
Both parts of the thesis deal with the implementation of QA-procedures. High 
quality data and study results can be achieved only by the usage of appropriate QA-
procedures, as presented in this work. Therefore, QA-measures should be 
implemented at all levels of a project and should be implemented permanently in 
project and evaluation routines. 
  




Magnetresonanztomographie (MRT)-Daten entstehen durch ein komplexes 
Verfahren. Es gibt dadurch viele mögliche Fehlerquellen, die zu einem schlechteren 
Signal führen können. Beispielsweise können defekte Bauteile des MRT-Scanners, 
Veränderungen des statischen Magnetfeldes (z.B. durch eine sich bewegende Person 
im MRT-Scannerraum) oder Veränderungen der Messsequenzen das Signal-zu-Rausch 
Verhältnis (SNR) negativ beeinflussen. Daher ist eine umfassende Qualitätssicherung 
(QS) nötig. Eine QS sollte sich neben der Qualität der MRT-Daten unter anderem mit 
dem Einhalten festgelegter Protokolle und der Dokumentation befassen. Um die 
Qualität der MRT-Daten zu untersuchen, gibt es zwei Möglichkeiten. Zum einen 
werden regelmäßig Wasser- oder Gel-gefüllte Behältnisse (sogenannte „Phantome“) 
gemessen. Anhand dieses Signals, welches im besten Fall immer stabil ist, kann die 
generelle Performanz des MRT-Scanners getestet werden. Zum anderen werden die 
eigentlich interessierenden Daten, meist Humandaten, direkt auf bestimmte 
Signalparameter (z.B. SNR, Bewegungen) geprüft. 
Die vorliegende Arbeit besteht aus zwei Teilen. Im ersten Teil wurde für eine große 
multizentrische MRT-Studie, FOR2107, ein studienspezifisches QS-Protokoll entwickelt. 
FOR2107 hat das Ziel, die Ursachen und den Verlauf von affektiven Störungen, 
unipolaren Depressionen und bipolaren Störungen unter der Berücksichtigung von 
klinischen und neurobiologischen Effekten zu untersuchen. Kern von FOR2107 ist die 
MRT-Messung von mehr als 2000 Probanden in einem longitudinalen Design (derzeit 
Wiederholungsmessung nach zwei Jahren; geplant sind weitere Messungen nach fünf 
Jahren). Um MRT-Daten und Krankheitsverlauf zusammenzubringen, müssen die MRT-
Daten über den Verlauf der Studie stabile Ergebnisse liefern. Die Sicherstellung dieser 
Stabilität wird in diesem Teil der Arbeit behandelt. Hierzu wurde eine umfangreiche QS 
aufgesetzt, basierend auf Phantommessungen, Analyse der Humandaten, Prüfung der 
Einhaltung der Protokolle, usw. Neben der Entwicklung von Parametern für die 
Charakterisierung der MRT-Daten wurden die QS-Protokolle während der Studie 
verbessert. Die Unterschiede zwischen den Standorten und die Auswirkung dieser 
Unterschiede auf die Analyse der Humandaten wurden analysiert. Die umfassende 
Qualitätssicherung für die FOR2107 Studie zeigte, dass signifikante Unterschiede im 
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MRT-Signal (für Human- und Phantomdaten) zwischen den beteiligten Zentren 
bestehen. Auftretende Probleme konnten somit entweder rechtzeitig erkannt und 
behoben werden oder müssen für aktuelle und zukünftige Auswertungen der 
Humandaten beachtet werden. 
Im zweiten Teil der Arbeit wurde ein QS-Protokoll (und die frei verfügbare 
zugehörige Software „LAB–QA2GO“) entwickelt und getestet, welches leicht für 
einzelne Studien oder zur Kontrolle der Qualität eines MRT-Scanners umsetzbar ist. 
Dies geschah vor dem Hintergrund, dass trotz der Existenz von geeigneter, frei 
verfügbarer QS-Software für MRT-Messungen an vielen Standorten und in vielen 
Studien keine explizite QS durchgeführt wird. Durch diese Software ist es möglich, ein 
QS-Protokoll ohne großen Aufwand und IT-Kenntnisse an einem MRT-Scanner oder in 
einer Studie aufzusetzen. 
Beide Teile der Arbeit beschäftigen sich mit der Durchführung von QS-
Maßnahmen. Erst durch den Einsatz von geeigneten QS-Maßnahmen, wie in dieser 
Arbeit vorgestellt, können qualitativ hochwertige Daten und Studienergebnisse erzielt 
werden. Daher sollten QS-Maßnahmen auf allen Ebenen eines Projekts durchgeführt 
werden und permanent in Projekt- und Auswerteroutinen realisiert werden.  
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1 INTRODUCTION  
Since the 1990s, functional Magnet Resonance Imaging (fMRI) has become a 
common tool to investigate the human brain (Ogawa et al. (1990, 1992)), allowing the 
exploration of its structure and its functioning with a non-invasive procedure. Based on 
these features, the Magnet Resonance Imaging (MRI) technology became 
tremendously important within the field of neuroscience. Besides MRI, other 
techniques exist to investigate the human brain e.g., Electro-encephalography (EEG), 
Magnetoencephalography (MEG) or Positron Emission Tomography (PET). Each 
technique has a specific relation between spatial and temporal resolution which is 
highlighted in Figure 1. The EEG technology for instance has a high temporal but a 
relatively poor spatial resolution and measures the brain's electrical activity directly. 
The MEG acquisition has a good temporal and spatial resolution and uses like EEG the 
electrical activity of the neurons. PET has a good spatial, but poor temporal resolution, 
and records the metabolic activity. The fMRI has a fair temporal and spatial resolution 
and uses the changes in blood flow to detect the functional activity in the brain. 
To analyze the function of the brain, fMRI is a prevalent method used in many 
neuroimaging studies. The localization of a specific brain function (functional 
segregation) and the investigation of connectivity between brain regions (functional 
integration) are hereby of major interest. Google scholar1 lists about 870.000 “fMRI” 
entries. As stated above, this technique enables the investigation of the functional 
processes in the brain with a high spatial resolution. The current spatial resolution of 
an fMRI acquisition on a 3 Tesla MRI-scanner is between 2.0 and 3.2 mm (Thanh Vu et 
al. 2017; Jahanian et al. 2019). By using a 7 Tesla MRI-scanner in human data, the in-
plane resolution results can be improved to sub-millimeter level (Murphy et al. 2019). 
Abe et al. (2019) improved the resolution up to 100  μm3 at a rat MRI-scanner.  
In general, fMRI-studies analyze functional signal changes which are typically just a 
small fraction (~1-5 %) of the raw MRI-signal intensity (Friedman and Glover 2006). In 
the 1990s research began with studies which had a small amount of participants 
                                                     
1
 https://scholar.google.de/ (last visited 10/26/2019) 




Figure 1: Graphic showing the relative spatial and temporal resolutions of common 
neuroimaging techniques (EEG: Electro-encephalography, IEEG: Invasive 
Electroencephalography, MEG: Magnetoencephalography, MRS: Magnetic Resonance 
Spectroscopy, fMRI: functional MRI, SPECT: Single Photon Emission Cranial Tomography, and 
PET: Positron Emission Tomography) (Adapted from Zamrini et al. 2011). 
(n ~ 20), mostly performed at one center. Today, especially in psychiatric research, 
large cohort studies (n >> 100) are performed at multiple centers. Apart from this basic 
scientific research, the MRI-technology is increasingly used also in clinical context, e.g., 
to locate a tumor in the brain (Talos et al. 2010; Metwali et al. 2019; Zhavoronkova et 
al. 2019).  
To obtain results which highlight active brain regions based on the experiment or 
differences in the brain structure (see Figure 4 in manuscript 1), many different steps 
have to be performed. First, the data needs to be acquired. Therefore, the right MRI-
scanner parameters have to be chosen. If smaller brain regions, like the amygdala, are 
investigated, the MRI-scanner parameters must be adapted for the measurement (e.g., 
adaption of the measurement volume)(Morawetz et al. 2008). If a whole brain analysis 
is performed, a bigger measurement volume must be set to cover the whole brain(Yan 
2010; Craddock et al. 2012). This is just one of many MRI-parameters which can be 
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adapted. Others, such as the time of repetition (TR), the time of echo (TE), the voxel 
size or the matrix size, are important as well to obtain high quality data. Even if the 
same parameters were used for the measurements, differences in the quality of the 
data can be present based on the differences of participants who were measured. 
Because of the large variability of both equipment parameter-settings and of patients, 
a calibrating, measurable standard is needed to ensure the quality of the MRI-data. 
This quality standard is not absolute and will change during the course of a study due 
to (i) different external aspects and (ii) different MRI-image characteristics. An external 
change (i) could be the result of a MRI-protocol change during the study or due to 
insufficient equipment which affects the MRI-scanner. These external changes result in 
a different temporal stability of the MRI-signal or a change of the MRI-image contrast 
(ii). 
The quality of the MRI-data is important for the interpretation of the human MRI-
data analysis and the corresponding results. Stöcker et al. (2005) introduced the 
percent signal change (PSC) value, which describes the signal changes over the time 
course of a study for human MRI-data. This method qualifies the functional data over 
the time. Stöcker et al. separated the data of controls (c) and patients (p) into two 
quality levels (high (+) and low (-)) (Figure 2). Some regions in the low quality control 
group have a higher intensity than the high quality control group. In the low quality 
patient group some regions are not present in comparison to the high quality patient 
group. This highlights the differences in the quality of the data which effects the results 
of the analysis. To detect the changes between MRI-signal that is associated with the 
time course of a disease and signal changes caused by alterations in the MRI-scanner 
environment, a stable MRI-signal is important.  
To monitor the stability of the MRI-signal, different quality assurance (QA) mechanisms 
are needed. These mechanisms are recorded in a QA-protocol. Besides the MRI-signal, 
other MRI-related (e.g., choice of scan parameters, selection of paradigms) and non-
MRI-related factors (e.g., data storage, long-term management of measurement 
procedures) should be included in the QA-protocol to improve the overall quality and 
to reduce the inter-site variability of a study. Therefore, a comprehensive QA-protocol 
is necessary, especially in large, longitudinal, multicenter MRI-neuroimaging studies. 
Such a protocol also includes careful planning and coordination (Glover et al. 2012). 




Figure 2: Statistical Parametric Mapping (version: 2) one-sample t-test results (random 
effects) for the working memory contrast in the multicenter study. Groups of size n=16 were 
analyzed. All results are thresholded at p=0.001 (uncorrected). C+ and C- results are similar. 
Furthermore, the cluster size is larger in the C+ group. The P-group has extremely low data 
quality, which is reflected by the low activation in the statistical maps. It is the only case that 
does not show any activation when thresholding at p=0.05 with correction for multiple 
comparisons (Stöcker et al. 2005).  
The documented adherence to QA-protocols has become a key benchmark to evaluate 
the quality, impact and relevance of a study (Van Horn and Toga, 2009).  
As important as QA-protocol documentation is, most MRI-studies do not describe 
any QA of their study or their MRI-data (e.g., Paret et al. (2016) or Vignali et al. (2019)). 
Even if a study performs QA of the MRI-data, the respective description is not detailed, 
but mostly refer to the Friedman and Glover study (e.g., Krystal et al. (2018)). 
Friedman and Glover (2006) were the first to present a QA-protocol which uses an gel 
filled object (so-called "phantom") in a multicenter study to investigate the stability of 
the MRI-signal over time. They also pointed out that modern MRI-systems show in 
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general overall high technical quality, but image characteristics (e.g., signal-to-noise 
ratio (SNR)) may change over the time of a study (Friedman and Glover 2006). 
Literature describes many QA-protocols now, mostly in the context of large-scale 
multicenter studies (Van Horn et al. 2009; Glover et al. 2012; Davids et al. 2014). 
Depending on the neuroscientific question at hand, some QA-protocols focus more on 
the quality assessment for structural (e.g., Gunter et al. (2009)) or than the functional 
MRI-data (e.g., Stöcker et al. (2005) or Friedman and Glover (2006)). Moreover, 
literature describes software tools that detect and remove movement artifacts (e.g., 
ARTRepair (Mazaika et al. 2009)) or investigate the temporal stability (i.e., stability of 
the MR-signal over the course of a measurement) of the signal (e.g., MRIQC (Esteban 
et al. 2017)). In human MRI-datasets, QA-protocols were also developed for more 
specialized problems e.g., multimodal settings such as the combined acquisition of MRI 
with EEG (Ihalainen et al. 2015) or PET data (Kolb et al. 2012). Other protocols were 
developed for a daily phantom QA-routine of MRI-data (Chen et al. n.d.; Peltonen et al. 
2017).  
To perform a QA-protocol analysis, these software tools need to be installed and 
set up for a given computer environment. The installation of these routines is often 
not straight-forward. It typically requires a fair level of technical experience, e.g., to 
install additional image processing software packages or to handle the dependence of 
the QA-tools on specific software versions or hardware requirements. Some QA-
algorithms require the installation of standard image processing tools (e.g., Artifact 
Detection Tool2 or PCP Quality Assessment Protocol (Zarrar et al. 2015)) while others 
are integrated in different imaging tools (Mindcontrol3 or BXH/XCEDE (Gadde et al. 
2012)). Some QA-workflows can be integrated in commercial programs, e.g., MATLAB4 
(CANlab5 or ARTRepair), or in large image processing systems (e.g., XNat (Marcus DS, 
Olsen TR, Ramaratnam M et al. 2007); C-Mind (Lee et al. 2014)). Other QA-workflows 
                                                     
2
 http://web.mit.edu/swg/software.htm (last visited on 10/26/2019) 
3
 https://github.com/akeshavan/mindcontrol (last visited on 10/26/2019) 
4
 https://www.mathworks.com/ (last visited on 10/26/2019) 
5
 https://canlab.github.io/ (last visited on 10/26/2019) 
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can only be used online, by registering with a user account and uploading data to a 
server (e.g., LONI (Kim et al. 2019)). Commercial software tools (e.g., BrainVoyager 
(Goebel 2012)) mostly have their own QA-workflow included. Also some virtualization 
based QA-pipeline tools exist (e.g., MRIQC (Esteban et al. 2017)).  
MRI-phantoms (water or gel-filled objects) are generally used to monitor the 
stability of the MRI-scanner. MRI-phantoms have the advantage that they are not 
affected by instrumental drifts from biological variations and pathological changes, 
whereas human MRI-data has a lot of biological influences (Hellerbach 2013). Common 
MRI-phantoms are: the American College of Radiology (ACR) phantom (ACR 2005), the 
Eurospin test objects (Firbank et al. 2000), gel phantoms of the Functional 
Bioinformatics Research Network (FBIRN)-Consortium (Friedman and Glover 2006) or 
the Pro-MRI Agar6 phantom. Other projects are developing new phantoms (Olsrud et 
al. 2008; Tovar et al. 2015; Hellerbach et al. 2013). Each of these QA-phantoms was 
designed for specific purposes. The ACR phantom and the Eurospin test objects were 
designed to test the geometry of the MRI-system, whereas the gel phantoms were 
developed to control for the temporal stability especially in fMRI studies. In all 
scenarios, an accurate alignment of the phantom in the MRI-scanner is necessary, by 
using a phantom holder, in order to reduce the alignment time, reduce the variance of 
the data, and to improve the sensitivity of the QA-parameters (Vogelbacher et al. 
2016). 
A specific QA-protocol to monitor the performance of an MRI-scanner would 
enhance the assessment of the temporal stability of the acquired time series, both 
within a session and between repeated measurements. To reach that aim, different 
types of QA-routines could be applied. On the one hand, a study related QA-protocol 
could be set up to monitor both the study specific MRI-settings and to the study-
specific data (management). All (MRI-) parameters can be adapted to the setting used 
in the study (e.g., the investigation of one specific functional MRI-sequence). 
Measurements of a MRI-phantom could be performed at a specific time on a 
measurement day or subsequent to a human measurement. The advantage is a 
specific to the data, adapted QA-procedure which can easily be transferred to other 
                                                     
6
 http://pro-project.pl/pro-mri_agar (last visited on 10/26/2019) 
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institutes, if the study is a multicenter study. On the other hand, a QA-routine can be 
set up tailored to a specific center (the so-called center specific QA). This approach 
focuses on the monitoring of one MRI-scanner. A documented QA-protocol is used 
with a specific purpose (e.g., testing the cooling system of the MRI-scanner). It is 
executed routinely at defined time points with the goal to filter out the external 
influencing factors which cofounds data collection quality, i.e., controls for the same 
state of the MRI-scanner. 
In conclusion, the quality of MRI-data is important to rephrase MRI-data, which is 
related to the signal that is associated with the time course of a disease and not 
related to signal changes caused by alterations in the MRI-scanner environment. 
Therefore QA-protocols are used which not only analyze (phantom) MRI-data, but 
extend over all parts that are related to data acquisition. Considering only phantom 
measurements there are many phantoms and many routines described in the 
literature. The main idea of these MRI-measurements is the inspection of stability of 
different aspects (defined in each QA-protocol).  
In this work, two different questions concerning QA-procedures were investigated. 
First, the question how a QA-procedure must set up in a longitudinal multicenter study 
and second how the distribution and the usage of QA-tools can be improved. For the 
first question a gel phantom was used to monitor the temporal stability of the MRI-
scanners in the Marburg-Münster Affective Disorders Cohort Study 
(http://for2107.de/, MACS). MACS is a two-center research consortium studying the 
neurobiological foundations of affective disorders for a large amount of participants 
(n>2500). To improve the implemented QA-protocol, a phantom holder was used 
(Vogelbacher et al. 2016). By inspecting the phantom data, differences between the 
centers were detected. An evaluation of the different MRI-sequences for data 
acquisition in humans was necessary with regard to differences found in the phantom 
data. Respective difference could be observed, so that this has to be considered in the 
human data analysis. These outcomes point to the importance of QA-protocols and 
QA-analysis for a (MRI) study. To investigate the partly distributed usage of QA-
protocols a survey was performed, which revealed that QA is often too complex for the 
users. For the second question the LAB–QA2GO toolbox was implemented to minimize 
the inhibitions of setting up a QA-routine and to improve the distribution of QA-
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protocols. This toolbox provides QA-scripts for the ACR and gel phantom and can also 
calculate QA-parameters for structural and functional human MRI-datasets. The 
installation requires minimal effort and the tool is simple to use. All results are 
presented in a user-friendly web interface. 
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2 RESULTS OF THE STUDIES  
In the following section, the first part describes the implementation and 
improvement of a QA-protocol in a longitudinal multicenter study. The first part’s 
question results led to this thesis’s second question of how to improve the distribution 
and the usage of QA-tools for MRI-scanners. The existing software tool, LAB–QA2GO, 
was developed to improve the usage of QA tools and will be described in the last 
section. 
2.1 Study QA-protocol  
For the first question how to set up and improve a MRI specific QA-protocol a 
comprehensive study QA for the MACS study was installed. The basic idea of this QA-
protocol was to guarantee the stability of a MRI-signal across the duration of this 
ongoing large cohort study. About 2500 subjects will be recruited in total and two MRI-
measurements for each subject will be performed. For each subject different MRI 
weighted measurements (e.g., a T1 weighted measurement to measure the structure 
of the brain) will be acquired. To investigate the neuronal activity in order to the fMRI-
measurements are important, but functional signal changes are typically just a small 
fraction (~1-5 %) of the raw signal intensity (Friedman and Glover 2006). Therefore, a 
stable temporal MRI-signal is important to make sure that the first and last 
measurements of the study are comparable to each other. To test the temporal 
stability of the MRI-signal, a gel phantom measurement was performed after each 
human measurement using a standard study fMRI protocol. Based on a prior work 
(Vogelbacher et al. 2016), a phantom holder was introduced during the study to align 
the phantom into the scanner. The structural MRI, fMRI, and diffusion tensor imaging 
(DTI) data of 444 healthy control subjects was also investigated with regard to the 
extent of between-site differences. 
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During the study, each center had a major incident. The Marburg site had to 
replace the defective gradient coil of the MRI-scanner, and at the Münster site, the 
MRI-protocol was changed by activating the pre-scan normalize7 filter. 
To analyze the phantom data, a set of different QA-metrics of different QA-
protocols was compiled (Friedman and Glover 2006; Stöcker et al. 2005; Simmons et 
al. 1999; ACR 2005). These QA-metrics can be segmented into spatial (e.g., SNR or 
ghosting) and temporal (e.g., PSC or percent fluctuation) characteristics and statistics. 
For each human dataset, a related analysis method was used. For structural MRI-data 
the volumetric information were investigated by using the CAT12 toolbox8 to calculate 
the total intracranial volume (TIV), total gray matter volume (GMV), and total white 
matter volume (WMV). To detect the regions where significant volume differences 
were caused by spatially localized differences between MRI-images of both scanners, a 
voxel-based morphometry approach (VBM, (Ashburner et al. 2001)) was performed. 
For the functional MRI-data the PSC value (Stöcker et al. 2005) was calculated for each 
subject and for the DTI data the fractional anisotropy (FA) information was assessed. 
At both sites the phantom measurements were performed (1009 in Marburg, 205 
in Münster). In Marburg, 369 measurements were performed without phantom holder 
and 640 with holder. Of the 640 phantom measurements performed with the phantom 
                                                     
7
 MRI-imaging is increasingly performed, as in the present case, with arrays of small surface coils placed 
near the body. The advantage of using small surface coils is that they produce higher signal-to-noise 
ratios than would be possible from a larger, more distant coil. The disadvantage is non-uniformity of the 
signal. The depth of penetration of coils is inversely proportional to their diameters. Signals arising 
superficially in the subject are thus accentuated, while those deeper in the brain (e.g., the amygdala) are 
attenuated. It is possible, however, to make corrections for non-uniform receiver coil profiles prior to 
imaging. For Siemens scanners, this method is known as “pre-scan normalize”. The normalization 
process involves acquiring an additional pair of low resolution scans, one with the head coil receiving 
signals and the other with the body coil receiving signals instead. The body coil is used for radio 
frequency transmission in both cases. Then, under the assumption that the large body coil's receive 
profile is homogeneous across a head-sized object, when the pre-scan head coil image is divided by the 
pre-scan body coil image, the resulting image is essentially an image of the receive field of the head 
receiving coil. This image can then be used to normalize a target image, thereby removing the receive 
field heterogeneity. 
8
 www.neuro.uni-jena.de/cat (last visited on 10/26/2019) 
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holder, 428 took place before replacement and 212 after replacement of the defective 
gradient coil. In Münster, 165 measurements were done without the pre-scan 
normalize option and 40 measurements with this changed routine.  
The analysis of the phantom data showed that differences between the scanners, 
technical changes of a scanner (such as the replacement of the MRI-gradient coil) and 
changes in the QA-protocol (such as the introduction of a phantom holder) as well as 
changes in certain sequence parameters (such as adding the pre-scan normalization 
option) impacted many of the QA-statistics in a variety of ways. Based on the 212 
phantom measurements which have been acquired in Marburg using the phantom 
holder and after the coil change, the dependence of QA-statistics on the external 
variables temperature, time of day, and helium level was also investigated. Helium 
level does not seem to have an influence on any of the QA-statistics. Measurements 
during the second half of the day seem to have an effect on some QA-metrics, as well 
as measurements acquired above 20.8 °C room temperature. 
The T1-weighted structural images analysis showed that TIV, GMV, and WMV 
volumes significantly differ between the MRI-scanners, showing large effect sizes. The 
VBM analyses show that these structural differences observed between scanners are 
most pronounced in the bilateral basal ganglia, thalamus, and posterior regions. Using 
DTI data, a difference of the FA between sites in almost all regions was observed. The 
PSC values of the fMRI data showed a significant difference between the sites as well.  
In conclusion, a comprehensive QA-protocol is important to monitor a study and to 
detect changes in the study or a protocol. It is essential to account not only for inter-
site differences but also for hardware and software changes of the MRI-scanner setting 
during a MRI-study. Any changes in the MRI-setting should be noted and considered 
for the analysis. There is also a strong dependency between the reliable placement of 
the phantom and the resulting QA-statistics. Therefore the usage of a phantom holder 
to reduce the variance of the QA-statistics and to detect potential malfunctions of the 
scanner is recommended.  
2.2 QA-tool 
Based on the findings of the first question, a comprehensive QA-protocol should be 
used for every study (in the neuroscience field). Even if no study related QA-protocol is 
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used, a MRI specific QA-protocol should be applied. To underline the importance of 
the distribution and especially the usage of QA-protocols, a survey (in 2009) was 
performed in 240 university hospitals and research institutes in Germany, Austria and 
Switzerland (data unpublished) to investigate which kind of QA-protocols they 
routinely applied. The results show that some centers have a comprehensive QA-
protocol established but that in practice most researchers in the cognitive and clinical 
neurosciences have only a vague idea to what extent QA-protocols are implemented in 
their studies and how to deal with potential temporal instabilities of the MRI-system 
(Hellerbach 2013). However, there already exist a fair amount of QA-protocols to 
monitor the MRI-scanner stability which could be flexibly adapted to the given QA-
protocol and data by researchers (for an overview see e.g., Glover et al. (2012)). These 
routines are mostly publically available and need a fair level of technical experience 
regarding the installation. Many of these tools need additional preprocessing software 
(with a specific software version). This circumstance is a challenge for unexperienced 
researchers that deter them for performing QA. 
To help all researchers getting started to perform QA on MRI-systems, an easy-to-
use QA-tool (called LAB–QA2GO) was developed to minimize the inhibitions and to 
improve the distribution of QA-protocols. The tool was developed for users without a 
strong technical background or for MRI-laboratories without support of large core-
facilities. Based on the virtualization approach of personal computer hardware the 
integration on most computer systems is given and does not require particular 
hardware specifications. LAB–QA2GO is available in a virtual machine with 
NeuroDebian (Halchenko et al. 2012) as operating system. NeuroDebian provides a 
large collection of neuroscience software packages and is widely used in the 
neuroscience community. All necessary software tools (all open source software to 
avoid license fees) for the analysis are installed so that the working environment is 
preconfigured. LAB–QA2GO provides a fully automated QA-pipeline on data of ACR 
phantoms and gel phantoms. These phantoms are commonly used and cover 
geometric and temporal stability QA-test to characterize and monitor the MRI-scanner. 
In addition, the movement parameters of human fMRI and the noise level of structural 
human MRI-data are calculated as easily interpretable QA-parameters. It is easily 
possible to modify these pipelines and to extend the QA-analyses by adding self-
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designed routines (based on a modular implementation of the source code). The 
results of the analysis are presented in an easy readable and easy-to-interpret web 
based format. The tool and these results can be accessed via a web browser so that a 
very user friendly usage without any specific IT knowledge is guaranteed. This also 
reduces the maintenance work of the tool to a minimum. The tool and all QA-scripts 
are available for download on GitHub9. Based on the virtualization approach the LAB–
QA2GO can be set up in about 10 minutes and can easily be integrated into the given 
computer environment. The adaption to own data is necessary and can be performed 
in a few configuration steps. 
Another aspect of a QA-protocol is the documentation of processes. Therefore 
most centers have their own procedure, data structure or documents. To centralize all 
these procedures and documents a software solution could be used to make this 
information easily accessible for everybody. One solution for this problem is 
MediaWiki10 which is a web based system to store documents and helps organizing 
processes. This software is also integrated in LAB–QA2GO to give the users the 
possibility to document their procedures and their QA-protocol. 
To give the users not only the analysis methods, an application scenario to perform 
MRI-scanner QA is as well given as an example QA-protocol. This routine includes runs 
with the ACR phantom and the gel phantom. All measurements were performed as the 
first measurement of the day. The ACR phantom was measured twice and the gel 
phantom once a week. The fix QA-protocol for the ACR phantom was used to perform 
the measurements. For the gel phantom a new QA MRI-acquisition protocol was 
installed. It consists of a localizer, a structural T1-weighted sequence, a T2*-weighted 
echo planar imaging (EPI) sequence, a DTI sequence, another fast T2*-weighted EPI 
sequence and, finally, the same T2*-weighted EPI sequence as at the beginning. This 
protocol is used to test the cooling system of the scanner. The QA-metrics of the first 
and the last EPI sequence are used to assess the impact of a highly stressed MRI-
scanner on the imaging data. 
                                                     
9 https://github.com/vogelbac/LAB-QA2GO (last visited on 10/26/2019) 
10
 www.mediawiki.org (last visited on 10/26/2019) 
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In conclusion, to improve the usage and the distribution of QA-protocols for 
especially MRI-scanner a fully automated QA-pipeline for phantom and human MRI-
datasets was developed. This tool helps unexperienced users who have no QA-routine 
implemented but want to assess the quality of MRI-data or to characterize the long-
term performance of a MRI-scanner. By using the QA-metrics of the LAB–QA2GO tool, 
it is possible to detect outliers which could be an indication of insufficient data quality 
or a MRI-scanner malfunction. Based on the virtualization technique the LAB–QA2GO 
tool can easily be integrated into almost every computer environment and needs 
minimal maintenance costs. This tool can be used to realize either a study specific or 
centers specific QA-protocol. The adaption to locally used phantoms and MRI-settings 
can easily be realized by the usage of the user friendly web interface. 
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3 DISCUSSION  
This work illustrates the importance of comprehensive QA-protocols in high-quality 
fMRI studies, which are affected by control for MRI-scanner instabilities and protocol 
changes. MRI-scanner malfunctions are often detected after the study is finished 
(Friedman and Glover 2006), so a prompt QA-analysis based on a comprehensive QA 
protocol should be performed to detect these malfunctions or deviation of the QA-
protocol in time.  
3.1 Question 1: How to set up and use a study QA-protocol 
A comprehensive QA-protocol was implemented for the acquisition of MRI-data in 
the multicenter research consortium MACS. The protocol aimed to monitor scanner 
performance, to define benchmark characteristics, and to assess the impact of changes 
in scanner settings. Only the current QA-statistics published in the literature were 
included and implemented for this analysis. Any changes in the MRI-scanner setting 
(equipment or protocol) would have had a major negative impact on the QA-statistics. 
Each QA-statistic has limited information to identify malfunctions of the MRI-scanner. 
To detect abnormal behavior of these QA-statistics, which lead to a possible 
malfunction, the QA-values must be compared continuously to those values which 
represent a respective setting of the MRI-scanner.  
The general idea of QA-protocols is the monitoring of QA-statistics to identify 
possible malfunctions to aid researchers in excluding those measurements (Glover et 
al. 2012). Defined ranges of the QA-statistics are used to identify the outliers. Based on 
the results of the published QA-phantom data, a definition of normal ranges of each 
QA-statistics was not possible for either the whole study or especially for just one MRI-
scanner. The reason is that changes in the hardware or software of the MRI-scanner 
may have affected the QA-statistics and consequently the ranges of the QA-statistics. 
This non-reproducibility of published QA-phantom data demonstrates the need and 
importance of QA protocols (not only in MRI-studies). 
In general MRI-experiments have to deal with different types of variances 
(biological, technical and variances during the placement of the measurement 
volume). QA-protocols aim to monitor the technical variance of an experimental 
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setting (e.g., defective MRI-coils) independent of handling differences (Glover et al. 
2012). If a phantom is used, the biological variance is reduced close to zero, based on 
the apathy to vibrations of the MRI-scanner and the resemblance to human tissue 
incident to the resulting stable MRI-signal (Hellerbach 2013). The handling variance 
can be minimized by using a phantom holder (Vogelbacher et al. 2016), which shows a 
strong impact on almost all QA-statistics even though these QA-statistics are not able 
to monitor the technical variance independent of handling. It is also mentionable that 
some QA-statistics seems to monitor the handling differences more than technical 
variables of the MRI-scanner. This could be because the used gel phantom consists of 
homogenous material and the placement of the calculation slice (slice of interest (SOI)) 
is based on the placement of the phantom in the scanner. An inconsistent alignment of 
the phantom increases the variability of the QA-statistics. This leads to the fact that 
there is a strong dependence between the QA-statistics and the placement of the 
phantom. If the MRI-equipment is faulty and the effect in the resulting QA-statistics is 
smaller than the variability of the reference values, the malfunction remains 
undetected. As a workaround, to reduce the variability of the QA-statistics, the usage 
of a phantom holder in combination with a fix MRI-protocol is recommended and was 
used for this study. The advantage is not only the reduced alignment time of the 
phantom in the MRI-scanner, it also ensures the measurement of the same volume of 
the phantom over various phantom measurements (Vogelbacher et al. 2016). The 
decreased variability of the QA-statistics is the result of the used phantom holder and 
delivers reasonable values so that the easy detection of outliers is possible. Some of 
the detected outliers (or possible malfunctions) were caused by minor misplacements 
of the phantom in the scanner (handling variance) instead of technical instabilities. 
This does, of course, not mean that the phantom holder improves the quality of the 
MRI-scanner. In addition to the alignment problem, some QA-statistics seem to be 
sensitive to the time of day they have been acquired. This might be caused by heating 
up of the MRI-scanner due to the high amount of measurements over the day. An 
equal distribution of the measurements with regard to acquisition time or temperature 
is advisable. A revision of the QA-statistics should be performed in the future to detect 
the instabilities in the technical variances. 
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As an example to accentuate the need for a statistical review and an adjustment of 
the QA-statistics was, the MRI-manufacturer detected after about one and a half years 
after the start of the study a defective gradient coil in the MRI-scanner, and it was 
replaced at the Marburg site. An investigation of the QA-statistics before and after the 
replacement showed that some QA-characteristics showed significant differences in 
performance. Interestingly, the defect coil was not detectable in the QA-statistics, but 
was accidentally discovered during a regular maintenance service. This was surprising 
because the QA-statistics proved to be sensitive to any change in the MRI-setting. An 
accurate indication of the time point when the defect gradient occurs is not given. The 
gradient coil might have been defective since the beginning of the study or could be 
broken shortly before the maintenance service.  
In general, a strict adherence of a QA-protocol is a key benchmark in the evaluation 
of the quality, impact, and relevance of a study to the patient-level (Van Horn et al. 
2009). The successful execution of the QA-protocol depends on the dedication of the 
project teams to consistently apply the requirements of the protocol over the whole 
study phase. To help these teams to produce consistent results, it might be also helpful 
to implement the possibility of an external control (e.g., by presenting results and 
current working steps via the World Wide Web).  
As a second aspect the differences in the MRI-performance between two sites 
were analyzed, too. The study was designed first for only one site and was extended to 
another site in Münster. The stimulus equipment and the MRI-settings were 
standardized across both sites. The used MRI-hardware differs between the sites 
(same manufacture but different scanner model), so that the QA-values were different 
as well. This is not surprising because different studies reported this occurrence before 
(e.g., Abdulkadir et al. (2011); Bendfeldt et al. (2012); Clarkson et al. (2009); Reig et al. 
(2009); Saotome et al. (2012); Stonnington et al. (2008); Takao et al. (2012); Yendiki et 
al. (2010); Friedman and Glover (2006); Friedman et al. (2006)). Other studies report 
that the differences between the scanners were small in comparison to the differences 
caused by, for instance, disease or aging (e.g., Evans (2006); Kruggel et al. (2010); 
Abdulkadir et al. (2011); Bendfeldt et al. (2012); Stonnington et al. (2008)). These 
differences could have an impact to the effect sizes so that this should be mentioned 
during data analysis. 
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The installed QA-protocol highlights the differences in the performance of a MRI-
scanner if a hard- or software change has been realized. The impact for instance on 
volumetric data when using different scanners is comparable to the impact of age (18 
vs 70 years old) and sex of the participating subjects. A recommendation for this 
problem is handling the data of any hard- or software changes as data that is 
measured at a different scanner. For any human MRI-data analysis, a categorical 
variable, that represents the different scanners and the changes, should be used. 
3.2 Question 2: How to improve the distribution of QA-protocols 
For this thesis’s second question, the LAB–QA2GO tool was developed to distribute 
QA-procedures. The tool provides fully automated QA-routines of especially phantom 
MRI-data, but it can also analyze human data. The current version is able to run 
analysis of the ACR and gel phantoms. The ACR phantom is a widely used phantom for 
QA of MRI-data to test spatial properties of the MRI-scanner. The gel phantom is 
mainly used to assess the temporal stability of the MRI-data. In addition, QA-routines 
for human datasets were developed. The LAB–QA2GO tool is developed modularly to 
enable modifications of existing analyzes or to integrate other scripts easily. The tool is 
a virtual machine and has no specific hardware requirements. The approach of a 
virtual machine was used to have a closed environment and to preconfigure all needed 
software, so that the users do not have to install any software to perform the QA-
analysis. LAB–QA2GO is ready-to-use in about 10 minutes and only a few configuration 
steps have to be performed to set it up. 
The results of the LAB–QA2GO analysis are presented in tabular and graphical form 
in a user-friendly and easy-to-interpret web based format. The timeline graphs, 
presented on the overview result page, help the users to identify the outliers. An 
acceptance range is highlighted in each graph, as well as a warning sign if a 
measurement is an outlier. These outliers could indicate a malfunction of the scanner. 
To access the web interface, no specific IT knowledge is needed. The tool is developed 
in a way that only minimal maintenance work is needed by the operator. 
All analysis scripts are available for download as well, if a user wants to integrate 
the QA-routine into an already existing environment. This requires a specific degree of 
technical experience though. Other tools, which are described in the literature to 
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assess MRI-stability e.g., Glover et al. (2012), are also publically available but do not 
provide the configured environment as the LAB–QA2GO tool do. Most of these tools 
require pre-installed analysis software (e.g., MATLAB) to run their analysis scripts, so 
LAB–QA2GO. This installation normally needs a fair level of technical experience. So 
LAB–QA2GO can be a tailor-made solution for user without a strong technical 
background. This tool can be used to assess the quality of MRI-data in small 
neuroimaging studies but can also be used as monitoring tool in multicenter studies to 
assess the long-term stability of different MRI-scanners. It can give direct feedback to 
its users and can detect possible outliers or changes in the hard- or software setting. 
Based on the pre-configuration and the virtualization approach, this tool is easily 
distributable and easy to use. 
A comprehensive QA-protocol should not only assess the quality of MRI-data, it 
needs to encompass technical issues and needs to optimize management procedures 
to achieve quality results (Glover et al. 2012). Especially at the beginning the study 
design is important. To document all these issues, a MediaWiki was integrated into this 
tool, to help the user realizing documentation for the study. 
The current version of the LAB-QA2GO toolbox uses relatively simple QA-statistics. 
These techniques were developed many years ago, but still provide useful and easily 
accessible information for modern MRI-scanners. Modern MRI-scanners are equipped 
with phased array coils, a number of amplifiers and multiplexers. Parallel imaging is 
also available for many years now, and multiband protocols become more and more 
common. Small changes in the performance of the MRI-system might therefore not be 
detected with these parameters. The implemented QA-metrics should not be 
considered as “ground truth”. As mentioned before, an adjustment of these statistics is 
recommended. In the literature, more sophisticated QA-metrics are available, 
especially for the assessment of modern MRI-scanners with multi-channel coils and 
modern reconstruction methods (Dietrich et al. 2007, 2008; Robson et al. 2008; 
Goerner et al. 2011; Ogura et al. 2012). Their usage would increase the sensitivity of 
the QA-metrics with respect to possible hardware malfunctions. The adapted analyses 
workflows for the multiband protocols could be easily integrated based on the 
modular implementation of LAB-QA2GO. This tool is under further development and 
will be continuously updated to adapt for modern MRI-systems. 
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3.3 Conclusion and Future work 
This work described two different QA related questions. The first question 
addressed an installation of a comprehensive study QA-protocol which is able to 
detect differences within and between scanners and any changes in the hard- and 
software environment. The second question dealt with the distribution and usage of 
automated MRI-QA-analysis using the LAB–QA2GO toolbox. The used analysis methods 
focused on monitoring the stability of an MRI-signal, which is a specific part of the 
wide QA-field. It must be clear that there are many other procedures which have to be 
controlled, to create a high quality MRI-study (e.g., careful planning (Glover et al. 
2012)). Therefore a general QA-management should be included in every study to 
cover all parts and improve the quality of the whole study. 
As mentioned before, the used QA-statistics are sufficiently sensitive to detect 
changes in the MRI-protocol or the MRI-hardware. These QA-statistics might, however, 
not be sufficient to characterize all aspects of modern MRI-scanner hardware. But they 
provide useful and easy accessible information also for today’s MRI-scanners. As a 
general recommendation a revision of these parameters should be performed. Also 
modern reconstruction methods, which are used for multi-channel MRI-coils, and their 
QA-statistics should be used in the future (Dietrich et al. 2007, 2008; Robson et al. 
2008; Goerner et al. 2011; Ogura et al. 2012). 
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